Pinned Tweet
After eight solid years of blood, sweat, and tears, today I am officially a Physician.
Introducing
Dr. Bankole Olumide, MBChB (Ogun)
•Best Student in Biochemistry
•Best Student in Pathology
•Best Student in Internal Medicine
olu. retweeted
Hi everyone, I’m Marvellous, some of you know me as Ini. I’m a few months from finishing my MPH at NYU. I planned for this year with a student loan and a summer internship but it didn’t come through. Then this month, MPOWER shut down. I was on their waitlist.
#FundDrMarvellous
Bioequivalence in a country like Nigeria with fake drugs epidemic and poor regulatory systems.
Let’s be honest with ourselves.
An important confounder however is that a patient who can afford 12 hourly dosing of Rocephin, would most likely present earlier, can afford important investigations and treatment modalities, thereby improving clinical outcomes.
olu. retweeted
It's funny how we are always trying to find a “gotcha moment” against one another among Nigerian healthcare workers. Our patients aren't better for it.
The context of the doctor's tweet is the prevalence of fake and substandard products, as well as concerns about the quality of locally manufactured products. Admittedly, there will be exceptions, but these concerns cannot simply be dismissed.
His statement isn't necessarily borne out of ignorance or malice. It reflects anecdotal evidence and clinical experiences of patients responding differently to different brands of the same drugs. This is an experience shared by doctors, pharmacists and patients alike.
With that being said, the response to this kind of conversation should be education, not belittlement; intellectual, not sentimental; and respectful, not condescending. Professional disagreements should be opportunities to exchange knowledge and improve practice, not occasions to demonstrate superiority over colleagues.
The goal should be better patient outcomes, not winning arguments against one another.
olu. retweeted
I have been avoiding this conversation since yesterday but it seems you guys are happy pretending we don't have a standardisation problem across Nigerian sectors including the drug industry.
So here's global peer reviewed evidence that generics are not universally bioequivalent. Even the local research in Ibadan had "a few cases"
Finally let's remember that because it happened in the lab doesn't mean it will happen in-vivo.
olu. retweeted
I hope the furosemide 'fest' brand whose company is in kano and is not in NAFDAC greenbook has same bioequivalence with lasix?
I don't even have these details, this is why I clamour for very good pharmacist grounded in pharmaceutical evidence and I want to learn from them.
olu. retweeted
Replying to @Walk_yea
For sometime I struggled whenever my Pharmacy colleague taught a particular module on our Global Health course and will say similar things to what the Doctor said.
This year he came with enough evidence to support his stance and I had no words. The truth is, in many emerging markets, there a lot of substandard generics in circulation.
Denying that is pretending that we do not see what happens daily in our hospital wings. We can't put our heads under the sand and pretend that we have organised standards yet we have a massive fake drug problem.
Guess I’ll spend a part of my weekend digging on Rocephin vs other brands of Ceftriaxone.
olu. retweeted
Had this same argument with some colleagues a few days ago.
“Residency-shaming” people is not it at all. Not everyone will be and want to be specialists and that’s not mediocre.
We need to stop making it seem like anyone who doesn’t go for residency is making a bad decision.
Let people do their thing please.
Can this be tested in the court?
Roughly 1 in 3 adult Nigerians are hypertensive.
If a man has a stroke in Ijebu Ode, where can he get a CT scan done?
On the flip side, there’s really no need for the HCP to express that he recognized her just after a private procedure, if it happened as she reported.

























